Fei Chen
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Wnt/β-catenin signaling in development and cancer
- RNA Research and Splicing
- RNA modifications and cancer
- Cancer-related gene regulation
Papers in
-
- RNA Research and Splicing 13
- RNA modifications and cancer 9
- Mitochondrial Function and Pathology 5
- Wnt/β-catenin signaling in development and cancer 5
- Cell Biology 21
- Hippo pathway signaling and YAP/TAZ 6
- Co-authors
- Yu Sun (3 shared papers)Ying Wang (1 shared paper)Guohong Hu (1 shared paper)Liangyu Lin (1 shared paper)Yufang Shi (1 shared paper)Pengfei Yu (1 shared paper)Xueqian Zhuang (1 shared paper)Yongju Lu (5 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Hepatology (2 papers)Nucleic Acids Research (2 papers)The International Journal of Biochemistry & Cell Biology (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fei Chen
109 papers receiving 3.4k citations
Fei Chen's Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 411
- Molecular Biology 1.8k
- Cell Biology 360
- Oncology 468
- Cellular and Molecular Neuroscience 340
Countries citing papers authored by Fei Chen
This map shows the geographic impact of Fei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Chen more than expected).
Fields of papers citing papers by Fei Chen
This network shows the impact of papers produced by Fei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Chen. The network helps show where Fei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New horizons in tumor microenvironment biology: challenges and opportunities Hit paper breakdown → | 2015 | 572 |
| 2 | Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation Hit paper breakdown → | 2019 | 250 |
| 3 | 2007 | 184 | |
| 4 | 2008 | 133 | |
| 5 | 1994 | 132 | |
| 6 | 2011 | 118 | |
| 7 | 1999 | 95 | |
| 8 | 2007 | 92 | |
| 9 | Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway. | 2017 | 81 |
| 10 | 2012 | 80 | |
| 11 | 2008 | 76 | |
| 12 | 2002 | 74 | |
| 13 | 1997 | 64 | |
| 14 | 2019 | 57 | |
| 15 | 2015 | 54 | |
| 16 | 1998 | 52 | |
| 17 | 2003 | 52 | |
| 18 | 2018 | 52 | |
| 19 | 2014 | 52 | |
| 20 | 2000 | 49 |
About Fei Chen
Fei Chen is a scholar working on Molecular Biology, Cell Biology, Cellular and Molecular Neuroscience, Cancer Research and Oncology, having authored 114 papers that have together received 3.5k indexed citations. Recurring topics across this work include RNA Research and Splicing (13 papers), RNA modifications and cancer (9 papers), Hippo pathway signaling and YAP/TAZ (6 papers), NF-κB Signaling Pathways (6 papers), Liver physiology and pathology (5 papers), Cancer Cells and Metastasis (5 papers), Mitochondrial Function and Pathology (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). The work is most often cited by research in Cancer Research (411 citations), Molecular Biology (1.8k citations), Cell Biology (360 citations), Oncology (468 citations) and Cellular and Molecular Neuroscience (340 citations). Fei Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yu Sun, Ying Wang, Guohong Hu, Liangyu Lin, Yufang Shi, Pengfei Yu, Xueqian Zhuang, Yongju Lu, Xianglin Shi and Zhen‐Ge Luo. Their work appears in journals such as Journal of Biological Chemistry, Hepatology, Nucleic Acids Research, The International Journal of Biochemistry & Cell Biology and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.